1.Two cases of acute radiation-induced skin injury caused by external exposure to 192Ir
Li LI ; Wei SHANG ; Yan LING ; Mi WANG ; Huisheng ZHANG ; Chiqiao LU ; Xiaohu ZHONG ; Shenglong XU ; Juan GUO ; Chang LIU ; Yulong LIU
Chinese Journal of Radiological Health 2026;35(1):56-61
Objective To introduce the causes of accidents and the diagnosis and treatment of two patients with radiation-induced skin injury admitted to our hospital in 2023, and to provide a reference for the clinical treatment of subsequent radiation-induced skin injury. Methods The clinical treatment process of two patients with acute skin injury caused by external radiation exposure were summarized and analyzed. Results The exposure history of the two patients was reconstructed, the flaw detection scenario was simulated, the biological dose and hand skin exposure dose were estimated, and the infrared thermal imaging device was used for dynamic monitoring. A comprehensive analysis was conducted based on clinical manifestations and other data. The diagnosis of “Xie” was excessive exposure combined with acute radiation-induced skin injury on both hands (Grade IV for the right hand palm, index finger, and middle finger and Grade II for the left hand little finger). The diagnosis of “Hao” was acute radiation-induced skin injury on both hands (Grade I). The two patients received different clinical treatment measures: “Xie” was treated with both local and systemic therapies, while “Hao” was mainly treated with systemic therapy. Conclusion After systematic and effective treatment, the radiation-induced skin injuries healed in both patients.
2.Emerging breakthroughs and future prospects of Claudin18.2 in targeted therapy and immuno-therapy for gastric cancer
Jiayu JIANG ; Zhen FANG ; Kexin ZHENG ; Baoshan CAI ; Yulong ZHAO ; Zhaodong LIU ; Changqing JING ; Leping LI ; Liang SHANG
Chinese Journal of Digestive Surgery 2025;24(3):343-349
Gastric cancer, a highly malignant tumor, has seen a persistent rise in global incidence in recent years. Claudin 18.2, a protein with highly specific expression in gastric cancer, has emerged as a prominent research target in therapeutic development. The overexpression of Claudin 18.2 in gastric cancer cells and its abnormal surface exposure provide novel opportunities for targeted and immunotherapeutic interventions. Therapeutic approaches targeting Claudin 18.2 have shown promising initial results in clinical trials, primarily including monoclonal antibodies and chimeric antigen receptor T-cell therapies. The authors systematically summarize the biological characteristics, mechanism of action, clinical research progress, and future treatment prospects and challenges of Claudin 18.2.
3.Impact and mechanism of resveratrol on myocardial energy metabolism in exercise-induced fatigue rats
Yulong HU ; Shang XU ; Libing ZHANG ; Qiguan JIN ; Xianghe CHEN
Chinese Journal of Comparative Medicine 2025;35(8):39-47
Objective Investigating the effect and mechanism of resveratrol on cardiac function in exercise-induced fatigue rats by regulating mitochondrial energy metabolism.Methods Forty-eight healthy male Sprague Dawley rats(6~8 weeks old)were selected and divided randomly into a blank control(C)group,resveratrol administration(R)group,exercise-induced fatigue(E)group,and exercise-induced fatigue+resveratrol administration group(ER)(n=12 rats per group).Rats in the E and ER groups were subjected to weight-bearing 5%of their body weight for 60 minutes each day and exercise for 6 days per week for 6 weeks.Rats in the R and ER groups received resveratrol 50 mg/kg by gavage,1 hour after exercise.The biochemical kit was used to detect the indicators of motor fatigue,myocardial injury and mitochondrial energy metabolism enzymes in rat myocardium.The mRNA expression levels of myocardial energy metabolism related regulatory factors were detected by real-time fluorescent quantitative PCR(RT-qPCR).Results Plasma levels of blood urea nitrogen(BUN)and creatine kinase(CK)were significantly increased in rats in group E compared with group C(P<0.05,P<0.05),CK-MB and cTnI activity were also significantly increased(P<0.01,P<0.05),while activity levels of myocardial cytochrome C oxidase(COX)and succinate dehydrogenase(SDH)were significantly reduced(P<0.01,P<0.05).mRNA expression levels of the mitochondrial energy metabolism-related genes silent information regulator 1(SIRT1),peroxisome proliferator-activated receptor γ coactivator 1-α(PGC-1α),and estrogen receptor-related receptor α(ERRα)were also significantly reduced(P<0.01,P<0.01,P<0.01).Serum levels of BUN and CK were significantly decreased in the ER group compared with group E(P<0.05,P<0.05),while CK-MB and cTnI activities were significantly decreased(P<0.05,P<0.05),myocardial COX and SDH activities were significantly increased(P<0.01,P<0.05),and SIRT1,PGC-1α and ERRα mRNA levels were also significantly increased(P<0.05,P<0.01,P<0.01).Conclusions Resveratrol can effectively activate the sirtuin 1/peroxisome proliferator-activated receptor γ coactivator 1α/estrogen-related receptor α signaling pathway,improve myocardial energy metabolism in exercise-fatigued rats,and protect against myocardial injury.
4.Progress of research on epidemiology and drug resistance mechanism of Elizabethkingia anopheles infection
Jie SUN ; Yulong ZONG ; Yongpeng SHANG ; Shanshan WANG ; Fangyou YU
Chinese Journal of Nosocomiology 2025;35(20):3188-3193
In recent years the detection rate of Elizabethkingia anopheles(EA)in China has shown an upward trend,making it one of the important pathogens causing hospital and community infections.EA accounts for 59.3%to 96.2%of the Elizabethkingia species,and can cause meningitis,pneumonia,bacteremia,etc.There are limited researches on its pathogenic mechanism,which mainly involves various virulence factors.EA is a mul-tidrug-resistant bacterium,with drug resistance mechanisms including biofilm formation,efflux pumps and carry-ing multiple resistance genes(such as GOB,BlaB).Currently,minocycline,piperacillin/tazobactam,trime-thoprim/sulfamethoxazole and rifampin are effective drugs for treating EA infections.Clinically,efforts are be-ing made to find the optimal antibacterial drug combination to achieve ideal therapeutic effects.This paper reviews the epidemiological characteristics,pathogenic mechanisms,drug resistance mechanisms and treatment options of EA,aiming to provide a reference for clinical prevention,control,diagnosis and treatment of EA infections.
5.An excerpt of British Society of Gastroenterology guidelines for diagnosis and management of autoimmune hepatitis(2025)
Yansheng LIU ; Yulong SHANG ; Ying HAN
Journal of Clinical Hepatology 2025;41(7):1303-1307
Recently,British Society of Gastroenterology has published the guidelines on the management of autoimmune hepatitis(AIH).The guidelines provide guidance for the diagnosis and management of patients with AIH and overlap syndrome by reviewing and summarizing existing clinical evidence.The guidelines mainly focus on AIH in adults,but it is also applicable to adolescents and older children.This article presents an excerpt of the recommendations from the guidelines.
6.Off-the-shelf human umbilical cord mesenchymal stromal cell product in acute-on-chronic liver failure: A multicenter phase I/II clinical trial.
Lina CUI ; Huaibin ZOU ; Shaoli YOU ; Changcun GUO ; Jundong GU ; Yulong SHANG ; Gui JIA ; Linhua ZHENG ; Juan DENG ; Xiufang WANG ; Ruiqing SUN ; Dawei DING ; Weijie WANG ; Xia ZHOU ; Guanya GUO ; Yansheng LIU ; Zhongchao HAN ; Zhibo HAN ; Yu CHEN ; Ying HAN
Chinese Medical Journal 2025;138(18):2347-2349
7.Influencing factors for quality of life in patients with primary biliary cholangitis: A systematic review
Yanqiu FANG ; Gui JIA ; Lina CUI ; Yulong SHANG ; Ying HAN
Journal of Clinical Hepatology 2025;41(10):2062-2067
ObjectiveTo investigate the core influencing factors for quality of life in patients with primary biliary cholangitis through a systematic review, and to provide an evidence-based basis for understanding such factors. MethodsThe databases including CNKI, Wanfang Data, CBM, VIP, PubMed, Embase, Web of Science, Ovid, Scopus, and Medline were searched for articles assessing the influencing factors for quality of life in patients with primary biliary cholangitis using PBC-40 scale published up to January 11, 2025. Quality assessment was conducted using the scale compiled by the Agency for Healthcare Research and Quality, and then a qualitative evaluation was performed for the basic situation of the studies included in the analysis. ResultsA total of 11 articles were included, and the results showed that age, sex, albumin, alkaline phosphatase, gamma-glutamyl transferase, direct bilirubin, total bilirubin, total bile acid, alanine aminotransferase, aspartate aminotransferase, body mass index, and high-density lipoprotein cholesterol were important influencing factors for quality of life in patients with primary biliary cholangitis. ConclusionInfluencing factors include demographic features, liver function parameters, and physical and metabolic indicators; however, due to the limited number of studies, more high-quality large-sample studies are needed in the future.
8.Evaluation of information quality in autoimmune liver disease-related videos on TikTok
Yanqiu FANG ; Gui JIA ; Yansheng LIU ; Lina CUI ; Yulong SHANG ; Ying HAN
Chinese Journal of Internal Medicine 2025;64(8):759-765
Objective:To evaluate the quality of information on autoimmune liver disease in videos on the TikTok short video platform.Methods:The keyword "autoimmune liver disease" was used to search the top 200 videos on TikTok in the default sorting order. Using the DISCERN video quality assessment tool and the structured content integrity evaluation tool, we assessed the quality of the information in each video in relation to the pertinent disease guidelines. Furthermore, we investigated any relationships between the quality of the videos and their characteristics (likes, comments, retweets, days and duration of uploading).Results:A total of 140 videos were included, 96.4% of which were provided by medical professionals. The content completeness scores for each dimension were as follows: definition, 1.0 (0.0, 1.0); symptoms, 0.0 (0.0, 1.0); risk factors, 0.0 (0.0, 0.5); assessment, 0.5 (0.0, 1.5); management, 0.5 (0.0, 1.0); and outcome, 0.0 (0.0, 1.0). Furthermore, 91.4% of videos with DISCERN scores of ≤50 were of "fair" quality or below. Additionally, the difference in DISCERN scores between videos from different publishers was not statistically significant ( P>0.05). The number of likes, comments, favorites, retweets, and video duration had a strong positive correlation with the overall DISCERN score ( r=0.17, 0.18, 0.25, 0.26, 0.44, all P<0.05). Conclusions:The overall quality of videos related to autoimmune liver disease on the TikTok video platform is low. Therefore, publishers should focus on the comprehensiveness and accuracy of the information. Additionally, the TikTok platform should optimize its video review mechanism to provide the public with more accurate and reliable health information.
9.Progress of research on epidemiology and drug resistance mechanism of Elizabethkingia anopheles infection
Jie SUN ; Yulong ZONG ; Yongpeng SHANG ; Shanshan WANG ; Fangyou YU
Chinese Journal of Nosocomiology 2025;35(20):3188-3193
In recent years the detection rate of Elizabethkingia anopheles(EA)in China has shown an upward trend,making it one of the important pathogens causing hospital and community infections.EA accounts for 59.3%to 96.2%of the Elizabethkingia species,and can cause meningitis,pneumonia,bacteremia,etc.There are limited researches on its pathogenic mechanism,which mainly involves various virulence factors.EA is a mul-tidrug-resistant bacterium,with drug resistance mechanisms including biofilm formation,efflux pumps and carry-ing multiple resistance genes(such as GOB,BlaB).Currently,minocycline,piperacillin/tazobactam,trime-thoprim/sulfamethoxazole and rifampin are effective drugs for treating EA infections.Clinically,efforts are be-ing made to find the optimal antibacterial drug combination to achieve ideal therapeutic effects.This paper reviews the epidemiological characteristics,pathogenic mechanisms,drug resistance mechanisms and treatment options of EA,aiming to provide a reference for clinical prevention,control,diagnosis and treatment of EA infections.
10.Analysis of clinical characteristics and current diagnosis and treatment status of IgG4-related diseases in the real world
Xiufang WANG ; Lina CUI ; Gui JIA ; Linhua ZHENG ; Ruiqing SUN ; Juan DENG ; Yulong SHANG ; Changcun GUO ; Ying HAN
Chinese Journal of Hepatology 2025;33(7):645-651
Objective:To retrospectively analyze the current status of consultation, clinical characteristics, and treatment status of patients with IgG4-related disease (IgG4-RD) in order to provide assistance and a basis for early and standardized diagnosis and treatment.Methods:IgG4-RD cases admitted to our hospital from June 2015 to October 2023 were collected. The details of patients' basic information, initial symptoms, department visits, laboratory and imaging findings, histopathological examination results, and treatment plans were recorded. A statistical descriptive analysis was performed on the data.Results:A total of 105 patients with IgG4-RD were included, with a median age of 59.0 (18.0, 78.0) years. The main departments visited were clinical immunology and gastroenterology (83.8%, 88/105). The median diagnostic duration was eight months, with a maximum of 300 months, and 33.3% (35/105) of patients needed over one year for diagnosis. 92 cases underwent histopathological examinations and IgG4 staining, with a total positivity rate of 87.0% (80/92). Among these, sixteen cases underwent pathological examination after surgery, with a positivity rate of 100%; the remaining 76 cases out of 92 underwent liver biopsy, with a positivity rate of 76.1%. Out of these, there were 22 cases from the pancreas, 21 from the submaxillary gland, nine from the labial gland, and seven each from the duodenal papilla and liver, with positivity rates of 81.8%, 81.0%, 55.6%, 85.7%, and 85.7%, respectively. Eleven cases (10.5%) with normal serum IgG4 were diagnosed based on multi-organ involvement and pathological results. 94 cases (89.5%) had elevated IgG4, with a predominance of>2.70 g/L. The median follow-up period for the 87 cases was 14 months. Two cases had poor response, twelve patients relapsed, five cases relapsed without combined drug treatment after surgery, five cases relapsed due to drug withdrawal, and two cases relapsed while tapering off steroids.Conclusions:As a multisystem disease, IgG4-RD still faces the difficulties of time-consuming diagnosis and inappropriate treatment. Therefore, it is necessary to rely on a multidisciplinary collaboration model to improve the awareness level and promote the early and standardized diagnosis and treatment of patients with IgG4-RD.

Result Analysis
Print
Save
E-mail